Utilizing gametocyte immunity to reduce malaria transmission

Malaria parasites turn the bone marrow into a factory for producing the transmission stages that spread the disease to mosquitoes. The researchers have discovered that the human immune system naturally targets these transmission-stage parasites, and they now plan to map exactly how this immune response works. Current strategies to block malaria transmission focus on killing parasites inside mosquitoes, which requires complicated feeding experiments to test effectiveness. This approach is slow and difficult to scale. The team’s discovery that transmission stages develop in the bone marrow opens a new route: instead of targeting the mosquito, they aim to harness the human immune system to clear these parasites before they can be picked up by a mosquito. If successful, this work will identify the most promising surface proteins for a transmission-blocking vaccine. Such a vaccine would not prevent a person from getting malaria, but would stop them from passing the parasite to others—a critical tool for elimination campaigns. The project is fundamental science: it defines the basic rules of immunity against transmission stages. Similar foundational work on parasite biology has previously led to the only licensed malaria vaccine.